Inhibition of catecholamine synthesis during ontogenic development.
D000367:Age Factors; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism*; D001933:Brain Stem / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004027:Diencephalon / Q000378:metabolism; D004220:Disulfides / Q000494:pharmacology*; D004298:Dopamine / Q000096:biosynthesis*; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D006624:Hippocampus / Q000378:metabolism; D008636:Mesencephalon / Q000378:metabolism; D008781:Methyltyrosines / Q000494:pharmacology*; D009431:Neural Conduction; D009638:Norepinephrine / Q000096:biosynthesis*; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors*
D004220:Disulfides; D008781:Methyltyrosines; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D004298:Dopamine; D009638:Norepinephrine